WilmerHale Advises Aushon BioSystems in $6.14M Series C Financing

WilmerHale Advises Aushon BioSystems in $6.14M Series C Financing

Firm News

Aushon BioSystems, a global provider of protein biomarker measurement and analysis products and services via an innovative, cost-effective multiplex immunoassay platform that delivers exceptional performance with industry-leading ease-of-use, announced that it held the initial closing of a $6.14 million Series C Financing.

With a growing menu of more than 300 biomarkers in key therapeutic areas and advanced microarray printing technology, Aushon BioSystems' comprehensive suite of products and services offers a complete solution for customers—global leaders in the pharmaceutical, biotechnology, academic and diagnostic industries.

The WilmerHale team was led by Partner Mick Bain and included Senior Associate Stephanie Singer and Associate Jared Iverson.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.